发布求助
文献互助 智能选刊 最新文献

Journal of Law Medicine & Ethics最新文献

筛选
英文 中文
Prevalence and Use of Driver Monitoring Systems: A National Survey in the United States. 驾驶员监控系统的普及和使用：美国全国调查。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-07-12 DOI: 10.1017/jme.2024.33
Johnathon P Ehsani, Jeffrey Michael, Michelle Duren, Emmanuel Drabo, Ahmed Sabit
{"title":"<b>Prevalence and Use of Driver Monitoring Systems:</b> A National Survey in the United States.","authors":"Johnathon P Ehsani, Jeffrey Michael, Michelle Duren, Emmanuel Drabo, Ahmed Sabit","doi":"10.1017/jme.2024.33","DOIUrl":"https://doi.org/10.1017/jme.2024.33","url":null,"abstract":"<p><p>The purpose of this study was to measure the prevalence of use of driver monitoring systems among U.S. adults, and factors influencing their adoption. One in five U.S. adults has used driver monitoring, primarily to obtain a discount on insurance. Safety benefits and financial incentives are likely to influence adoption.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 S1","pages":"26-30"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INTRODUCTION. 引 言
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-07-12 DOI: 10.1017/jme.2024.80
Vineeta Gupta
{"title":"INTRODUCTION.","authors":"Vineeta Gupta","doi":"10.1017/jme.2024.80","DOIUrl":"https://doi.org/10.1017/jme.2024.80","url":null,"abstract":"<p><p>The National Public Health Law Conference: People. Policy. Progress., held October 2023, brought together more than 400 stakeholders in public health to explore how law and policy can be leveraged to advance health equity, improve data sharing for community health, protect access to reproductive health and facilitate system change.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 S1","pages":"6-8"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges for the Pro-Life Movement in a Post-Roe Era - ERRATUM. 后罗伊时代支持生命运动面临的挑战 - ERRATUM.
IF 2.1 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-02-26 DOI: 10.1017/jme.2024.32
Cathleen Kaveny
{"title":"Challenges for the Pro-Life Movement in a Post-<i>Roe</i> Era - ERRATUM.","authors":"Cathleen Kaveny","doi":"10.1017/jme.2024.32","DOIUrl":"10.1017/jme.2024.32","url":null,"abstract":"","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":" ","pages":"207"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139974257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telehealth after the Federal COVID-19 Public Health Emergency: Implications and Future Directions. 联邦 COVID-19 公共卫生紧急事件后的远程医疗：影响和未来方向。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-10-22 DOI: 10.1017/jme.2024.118
Minsoo Kwon, James René Jolin, Carmel Shachar
{"title":"Telehealth after the Federal COVID-19 Public Health Emergency: Implications and Future Directions.","authors":"Minsoo Kwon, James René Jolin, Carmel Shachar","doi":"10.1017/jme.2024.118","DOIUrl":"10.1017/jme.2024.118","url":null,"abstract":"<p><p>May 11, 2023, marked the end of the federal COVID-19 Public Health Emergency (PHE). During the PHE, regulatory flexibilities allowed telehealth to more effectively connect physicians providing care and patients seeking it. This paper discusses the implications of the end of the PHE on telehealth coverage, payment, reimbursement, and licensure, and exposes inconsistencies and inequities in extant state regulations.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 2","pages":"412-418"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Drug Shortages in the US and Germany (2016 - 2023). 美国和德国药物短缺对比分析（2016 - 2023 年）》。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-10-22 DOI: 10.1017/jme.2024.105
Emanuel Nussli, Miquel Serra-Burriel, Kerstin N Vokinger
{"title":"Comparative Analysis of Drug Shortages in the US and Germany (2016 - 2023).","authors":"Emanuel Nussli, Miquel Serra-Burriel, Kerstin N Vokinger","doi":"10.1017/jme.2024.105","DOIUrl":"10.1017/jme.2024.105","url":null,"abstract":"<p><p>This article analyzes trends in drug shortages in the US and Germany, the largest pharmaceutical market in Europe, between 2016 and 2023. It assesses the commonalities and differences between the countries in terms of active substances in shortage, time duration in shortage, and cyclic trends.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 2","pages":"488-497"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patent Claim Scope and Biosimilar Competition in the US and EU. 美国和欧盟的专利权利要求范围与生物仿制药竞争。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-10-22 DOI: 10.1017/jme.2024.133
Doni Bloomfield, Aaron S Kesselheim
{"title":"Patent Claim Scope and Biosimilar Competition in the US and EU.","authors":"Doni Bloomfield, Aaron S Kesselheim","doi":"10.1017/jme.2024.133","DOIUrl":"10.1017/jme.2024.133","url":null,"abstract":"<p><p>The US has found it hard to establish competition in the market for biologics, which are therapeutics derived from living cells. In the case of small-molecule drugs, the emergence of direct competition from generic drugs at the end of the exclusivity period has provided the impetus for price competition, leading to lower spending. In 2010, to spur competition in the biologics market, Congress created a simplified pathway for the US Food and Drug Administration (FDA) to approve comparable versions of biologic drugs called biosimilars. Biosimilar competition in the US has nonetheless remained weaker than in European peer countries. For example, as of August 2020, there were 52 biosimilars available in Germany, and only 15 in the US.<sup>1</sup> An important contributor to this \"biosimilar gap\" has been the fact that biosimilars to biologic blockbusters such as adalimumab (Humira) and etanercept (Enbrel) were only (or will only become) commercially available in the US several years after receiving FDA approval, while they were available in Europe years earlier.<sup>2</sup> Through the end of 2021, it took biosimilars a median of 301 days between receiving FDA approval and becoming available for use.<sup>3</sup> In one recent study, the median length of time between when a biologic drug was approved and when its first biosimilar was made available to US patients was 21.5 years.<sup>4</sup> This paucity of competition has contributed to high US spending on biologics. According to the Department of Health and Human Services, in 2022 41% of US drug expenditures was spent on biologics, which represented 16% of US prescriptions.<sup>5</sup>.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 2","pages":"439-442"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INTRODUCTION: Medical-Legal Partnerships: Equity, Evolution, and Evaluation - CORRIGENDUM. 简介：医学与法律的伙伴关系：公平、演变和评估》 - CORRIGENDUM.
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-04-16 DOI: 10.1017/jme.2024.50
Katherine L Kraschel, James Bhandary-Alexander, Yael Z Cannon, Vicki W Girard, Abbe R Gluck, Jennifer L Huer, Medha D Makhlouf
{"title":"INTRODUCTION: Medical-Legal Partnerships: Equity, Evolution, and Evaluation - CORRIGENDUM.","authors":"Katherine L Kraschel, James Bhandary-Alexander, Yael Z Cannon, Vicki W Girard, Abbe R Gluck, Jennifer L Huer, Medha D Makhlouf","doi":"10.1017/jme.2024.50","DOIUrl":"10.1017/jme.2024.50","url":null,"abstract":"","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":" ","pages":"208"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"A Most Equitable Drug": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development. "最公平的药物"：将康复血浆作为治疗 SARS-CoV-2 的临床研究如何为大流行后公共部门的药物开发方法提供有用信息。
IF 2.1 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-05-31 DOI: 10.1017/jme.2024.51
Quinn Grundy, Chantal Campbell, Ridwaanah Ali, Matthew Herder, Kelly Holloway
{"title":"\"A Most Equitable Drug\": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.","authors":"Quinn Grundy, Chantal Campbell, Ridwaanah Ali, Matthew Herder, Kelly Holloway","doi":"10.1017/jme.2024.51","DOIUrl":"https://doi.org/10.1017/jme.2024.51","url":null,"abstract":"<p><p>Interventional clinical studies of convalescent plasma to treat COVID-19 were predominantly funded and led by public sector actors, including blood services operators. We aimed to analyze the processes of clinical studies of convalescent plasma to understand alternatives to pharmaceutical industry biopharmaceutical research and development, particularly where public sector actors play a dominant role. We conducted a qualitative, critical case study of purposively sampled prominent and impactful clinical studies of convalescent plasma during 2020-2021.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 1","pages":"80-97"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141181256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building Successful Partnerships Between State Health Departments and Attorney General Offices: The Minnesota Example. 在州卫生部门和总检察长办公室之间建立成功的合作伙伴关系：明尼苏达州范例。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-07-12 DOI: 10.1017/jme.2024.37
Dana Farley, Carman Leone, Caroline Palmer
{"title":"<b>Building Successful Partnerships Between State Health Departments and Attorney General Offices:</b> The Minnesota Example.","authors":"Dana Farley, Carman Leone, Caroline Palmer","doi":"10.1017/jme.2024.37","DOIUrl":"https://doi.org/10.1017/jme.2024.37","url":null,"abstract":"<p><p>In recent years, the Minnesota Attorney General's Office and the Minnesota Department of Health have cultivated a productive partnership to strengthen the state's multidisciplinary response to overlapping health equity and social justice issues. This article describes shared efforts in three areas: post-conviction justice, drug overdose, and human trafficking/exploitation.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 S1","pages":"66-69"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Phenomenon of Teen Delay in Driving Licensure: Considerations at the Intersection of Mobility and Social Welfare for Emerging Adults. 青少年延迟取得驾驶执照的现象：考虑新兴成人的流动性和社会福利的交叉点。
IF 1.6 4区 哲学
Journal of Law Medicine & Ethics Pub Date : 2024-01-01 Epub Date: 2024-07-12 DOI: 10.1017/jme.2024.42
Federico E Vaca, Emmanuel Fulgence Drabo, Kaigang Li
{"title":"<b>The Phenomenon of Teen Delay in Driving Licensure:</b> Considerations at the Intersection of Mobility and Social Welfare for Emerging Adults.","authors":"Federico E Vaca, Emmanuel Fulgence Drabo, Kaigang Li","doi":"10.1017/jme.2024.42","DOIUrl":"https://doi.org/10.1017/jme.2024.42","url":null,"abstract":"<p><p>In 2021, there were 11.7 million licensed young drivers in the U.S. This is 1.5 million fewer young drivers compared to 2007. The phenomenon of delay in driving licensure among teens has notable implications for opportunities positioning them for life success when transitioning into emerging adulthood and in later life.</p>","PeriodicalId":50165,"journal":{"name":"Journal of Law Medicine & Ethics","volume":"52 S1","pages":"81-84"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信